Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Research

The burden of dermatitis from 1990–2019 in the Middle East and North Africa region

Authors: Saeid Safiri, Mehran Jaberinezhad, Seyed Ehsan Mousavi, Kimia Motlagh Asghari, Ali Shamekh, Seyed Aria Nejadghaderi, Mark J. M. Sullman, Yousef Houshyar, Elham Behrangi, Ali-Asghar Kolahi

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

There are several types of dermatitis, each capable of causing enduring changes that extend beyond physical discomfort. In severe cases, dermatitis can significantly affect mental health, social interactions, and the overall quality of life. This study reports the burden of dermatitis in the Middle East and North Africa (MENA) region from 1990 to 2019, according to sex, age category, and socio-demographic index (SDI).

Methods

Publicly available data regarding the point prevalence, incidence, and years lived with disability (YLDs) were collected from the Global Burden of Disease 2019 study for both the MENA region and its constituent countries. The point prevalence, incidence, and YLDs of dermatitis were represented as counts and age-standardised rates with 95% uncertainty intervals (UIs).

Results

In 2019, the age-standardised point prevalence of dermatitis was 2744.6 (2517.8–3003.1) per 100,000 population, which was 2.3% lower than in 1990. The YLD rate was 92.3 (55.6–143.4) per 100,000 population, which was 3.1% lower than in 1990. The largest point prevalence rates were observed among those aged 70–74, for both sexes. The 2019 MENA/Global DALY ratio was not above one in any age group for either sex. During the period 1990 to 2019, there was no clear correlation between the burden of dermatitis and the SDI level.

Conclusion

The dermatitis burden in the MENA region remained relatively stable from 1990 to 2019. Future prevention efforts should focus on improving healthcare access, health education, and workplace safety regulations.
Appendix
Available only for authorised users
Literature
1.
2.
Yew YW, Thyssen JP, Silverberg JI. A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics. J Am Acad Dermatol. 2019;80(2):390–401.PubMedCrossRef
3.
Yaneva M, Darlenski R. The link between atopic dermatitis and asthma-immunological imbalance and beyond. Asthma Res Pract. 2021;7(1):1–8.CrossRef
4.
Rycroft RJ, Menné T, Frosch PJ, Lepoittevin J-P. Textbook of contact dermatitis. Berlin/Heidelberg: Springer Science & Business Media; 2013.
5.
Mokos ZB, Kralj M, Basta-Juzbašić A, Jukić IL. Seborrheic dermatitis: an update. Acta Dermatovenerol Croat. 2012;20(2):98–104.
6.
Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Invest Dermatol. 2015;3(2).
7.
Bashyam AM, Ganguli S, Mahajan P, Feldman SR. Lifelong impact of severe atopic dermatitis on quality of life: a case report. Dermatol Ther. 2021;11:1065–70.CrossRef
8.
Teixeira C, Garcia MJ, Freitas A, Silva H. Impact of atopic dermatitis on the mental health of adolescents—literature review. Med Sci Forum. 2022;16(1):8.
9.
Talamonti M, Galluzzo M, Silvaggio D, Lombardo P, Tartaglia C, Bianchi L. Quality of life and psychological impact in patients with atopic dermatitis. J Clin Med. 2021;10(6):1298.PubMedPubMedCentralCrossRef
10.
Laughter M, Maymone M, Mashayekhi S, Arents B, Karimkhani C, Langan S, et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017. Br J Dermatol. 2021;184(2):304–9.PubMedCrossRef
11.
Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, et al. Global skin disease morbidity and mortality: an update from the global burden of disease study 2013. JAMA Dermatol. 2017;153(5):406–12.PubMedPubMedCentralCrossRef
12.
Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.CrossRef
13.
Mainar AS, Carrascosa J, Navarro-Artieda R. Economic impact of atopic dermatitis in adults: a population study (IDEA study). Value Health. 2017;20(9):A497.CrossRef
14.
Augustin M, Misery L, von Kobyletzki L, Armario-Hita J, Mealing S, Redding M. Unveiling the true costs and societal impacts of moderate-to-severe atopic dermatitis in Europe. J Eur Acad Dermatol Venereol. 2022;36:3–16.PubMedCrossRef
15.
Drucker AM, Wang AR, Li W-Q, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Investig Dermatol. 2017;137(1):26–30.PubMedCrossRef
16.
Xue Y, Bao W, Zhou J, Zhao QL, Hong SZ, Ren J, et al. Global burden, incidence and disability-adjusted life-years for dermatitis: a systematic analysis combined with socioeconomic development status, 1990–2019. Front Cell Infect Microbiol. 2022;12:861053.PubMedPubMedCentralCrossRef
17.
Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49.CrossRef
18.
Wang Y. Smoothing splines: methods and applications. New York: Chapman and Hall/CRC; 2019.
19.
Bach J-F. The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat Rev Immunol. 2018;18(2):105–20.PubMedCrossRef
20.
Urban K, Chu S, Giesey RL, Mehrmal S, Uppal P, Nedley N, et al. The global, regional, and national burden of atopic dermatitis in 195 countries and territories: an ecological study from the Global Burden of Disease Study 2017. JAAD Int. 2021;2:12–8.PubMedCrossRef
21.
Warshaw EM, Zhang AJ, DeKoven JG, Maibach HI, Belsito DV, Sasseville D, et al. Epidemiology of nickel sensitivity: retrospective cross-sectional analysis of North American Contact Dermatitis Group data 1994–2014. J Am Acad Dermatol. 2019;80(3):701–13.PubMedCrossRef
22.
Szepietowski JC, Reich A, Wesołowska-Szepietowska E, Baran E, Group ftNQoLiD. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level. Mycoses. 2009;52(4):357–63.PubMedCrossRef
23.
Holm EA, Esmann S, Jemec GBE. Does visible atopic dermatitis affect quality of life more in women than in men? Gend Med. 2004;1(2):125–30.PubMedCrossRef
24.
Osman M, Hansell AL, Simpson CR, Hollowell J, Helms PJ. Gender-specific presentations for asthma, allergic rhinitis and eczema in primary care. Prim Care Respir J. 2007;16(1):28–35.PubMedPubMedCentralCrossRef
25.
Renzi C, Mastroeni S, Mannooranparampil TJ, Passarelli F, Caggiati A, Potenza C, et al. Prevalence of atopic dermatitis, allergic rhinitis and asthma in Taiwan: a national study 2000 to 2007. Acta Derm Venereol. 2010;90:595–601.
26.
Dong W-l, An J, Yu M, Yin P, Xu T-l, Liu B, et al. The prevalence and year lived with disability of atopic dermatitis in China: findings from the global burden of disease study 2019. World Allergy Organ J. 2021;14(11):100604.PubMedPubMedCentralCrossRef
27.
Chan LN, Magyari A, Ye M, Al-Alusi NA, Langan SM, Margolis D, et al. The epidemiology of atopic dermatitis in older adults: a population-based study in the United Kingdom. PLoS One. 2021;16(10):e0258219.PubMedPubMedCentralCrossRef
28.
Salava A, Rieppo R, Lauerma A, Salo V. Age-dependent distribution of atopic dermatitis in primary care: a nationwide population-based study from Finland. Acta Derm Venereol. 2022;102:adv00738.PubMedCrossRef
29.
Ro BI, Dawson TL. The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of seborrheic dermatitis and dandruff. J Investig Dermatol Symp Proc. 2005;10(3):194–7.PubMedCrossRef
30.
Lima AL, Timmermann V, Illing T, Elsner P. Contact dermatitis in the elderly: predisposing factors, diagnosis, and management. Drugs Aging. 2019;36(5):411–7.PubMedCrossRef
31.
Ahlström MG, Thyssen JP, Wennervaldt M, Menné T, Johansen JD. Nickel allergy and allergic contact dermatitis: a clinical review of immunology, epidemiology, exposure, and treatment. Contact Dermatitis. 2019;81(4):227–41.PubMedCrossRef
32.
Blome C, Radtke MA, Eissing L, Augustin M. Quality of life in patients with atopic dermatitis: disease burden, measurement, and treatment benefit. Am J Clin Dermatol. 2016;17(2):163–9.PubMedCrossRef
33.
Murota H, Koike Y, Morisaki H, Matsumoto M, Takenaka M. Exacerbating factors and disease burden in patients with atopic dermatitis. Allergol Int. 2022;71(1):25–30.PubMedCrossRef
34.
Paul C, Griffiths CEM, Costanzo A, Herranz P, Grond S, Mert C, et al. Factors predicting quality of life impairment in adult patients with atopic dermatitis: results from a patient survey and machine learning analysis. Dermatol Ther. 2023;13(4):981–95.CrossRef
35.
Bonamonte D, Filoni A, Vestita M, Romita P, Foti C, Angelini G. The role of the environmental risk factors in the pathogenesis and clinical outcome of atopic dermatitis. Biomed Res Int. 2019;2019:2450605.PubMedPubMedCentralCrossRef
36.
Ng YT, Chew FT. A systematic review and meta-analysis of risk factors associated with atopic dermatitis in Asia. World Allergy Organ J. 2020;13(11):100477.PubMedPubMedCentralCrossRef
37.
Cui H, Mu Z. Prenatal maternal risk factors contributing to atopic dermatitis: a systematic review and meta-analysis of cohort studies. Ann Dermatol. 2023;35(1):11–22.PubMedPubMedCentralCrossRef
38.
Reitsma MB, Kendrick PJ, Ababneh E, Abbafati C, Abbasi-Kangevari M, Abdoli A, et al. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet. 2021;397(10292):2337–60.CrossRef
39.
Schütte MG, Tamminga SJ, de Groene GJ, Kezic S, van der Molen HF. Work-related and personal risk factors for occupational contact dermatitis: a systematic review of the literature with meta-analysis. Contact Dermatitis. 2023;88(3):171–87.PubMedCrossRef
40.
Jacobsen G, Rasmussen K, Bregnhøj A, Isaksson M, Diepgen TL, Carstensen O. Causes of irritant contact dermatitis after occupational skin exposure: a systematic review. Int Arch Occup Environ Health. 2022;95(1):35–65.PubMedCrossRef
41.
Yu J, Chen JK, Mowad CM, Reeder M, Hylwa S, Chisolm S, et al. Occupational dermatitis to facial personal protective equipment in health care workers: a systematic review. J Am Acad Dermatol. 2021;84(2):486–94.PubMedCrossRef
42.
Moon J, Reeder M, Atwater AR. Contact allergy to nickel: still #1 after all these years. Cutis. 2021;107(1):12–5.PubMedCrossRef
43.
Uter W, Werfel T, White IR, Johansen JD. Contact allergy: a review of current problems from a clinical perspective. Int J Environ Res Public Health. 2018;15(6):1108.PubMedPubMedCentralCrossRef
44.
Ahlström MG, Thyssen JP, Menné T, Johansen JD. Prevalence of nickel allergy in Europe following the EU Nickel Directive – a review. Contact Dermatitis. 2017;77(4):193–200.PubMedCrossRef
45.
Khatami A, Nassiri-Kashani M, Gorouhi F, Babakoohi S, Kazerouni-Timsar A, Davari P, et al. Allergic contact dermatitis to metal allergens in Iran. Int J Dermatol. 2013;52(12):1513–8.PubMedCrossRef
46.
Kakşi SA, Kahraman FC, Akdeniz N, Özen T. Results of the patch tests with European baseline series in children: five years of experience from a single center in Turkey and a review of the literature. J Cosmet Dermatol. 2023;22(3):1071–6.PubMedCrossRef
47.
Cortés H, Rojas-Márquez M, Del Prado-Audelo ML, Reyes-Hernández OD, González-Del Carmen M, Leyva-Gómez G. Alterations in mental health and quality of life in patients with skin disorders: a narrative review. Int J Dermatol. 2022;61(7):783–91.PubMedCrossRef
48.
Ahlström MG, Dietz JB, Wilke A, Johansen JD, John SM, Brans R. Evaluation of the secondary and tertiary prevention strategies against occupational contact dermatitis in Germany: a systematic review. Contact Dermatitis. 2022;87(2):142–53.PubMedCrossRef
49.
Araya M, Kulthanan K, Jiamton S. Clinical characteristics and quality of life of seborrheic dermatitis patients in a tropical country. Indian J Dermatol. 2015;60(5):519.PubMedPubMedCentralCrossRef
50.
Adalsteinsson JA, Kaushik S, Muzumdar S, Guttman-Yassky E, Ungar J. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol. 2020;29(5):481–9.PubMedCrossRef
51.
Leroy AK, Cortez de Almeida RF, Obadia DL, Frattini S, Melo DF. Scalp seborrheic dermatitis: what we know so far. Skin Appendage Disord. 2023;9(3):160–4.PubMedCrossRef
52.
Peano A, Johnson E, Chiavassa E, Tizzani P, Guillot J, Pasquetti M. Antifungal resistance regarding Malassezia pachydermatis: where are we now? J Fungi. 2020;6(2):93.CrossRef
53.
54.
55.
Xuan M, Lu C, He Z. Clinical characteristics and quality of life in seborrheic dermatitis patients: a cross-sectional study in China. Health Qual Life Outcomes. 2020;18(1):308.PubMedPubMedCentralCrossRef
Metadata
Title
The burden of dermatitis from 1990–2019 in the Middle East and North Africa region
Authors
Saeid Safiri
Mehran Jaberinezhad
Seyed Ehsan Mousavi
Kimia Motlagh Asghari
Ali Shamekh
Seyed Aria Nejadghaderi
Mark J. M. Sullman
Yousef Houshyar
Elham Behrangi
Ali-Asghar Kolahi
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-17836-z

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue

Research

Realization path and connotation of the Healthy China strategy: macroscopic perspective of dietary structure and the entry of individual health consciousness

Research

Assessing the price levels of medical service and influential factors: evidence from China

Research

The relationship between nighttime exercise and problematic smartphone use before sleep and associated health issues: a cross-sectional study

Research

Machine learning algorithms using national registry data to predict loss to follow-up during tuberculosis treatment

Research

Ten-year association between change in speech-in-noise recognition and falls due to balance problems: a longitudinal cohort study

Research

Associations between patterns of blood heavy metal exposure and health outcomes: insights from NHANES 2011–2016